The global genomics personalized health market is anticpated to be highly fragmented due to presence of large number of palyers in the regional and global market.
Some of the key players in the industry are Thermo Fisher Scientific, Inc., QIAGEN, Illumina, Inc., Bio-Rad Laboratories, Inc., Lonza Group, F. Hoffmann-La Roche AG, INVITAE Corporation, Interleukin Genetics Inc., Genetic Technologies Limited, Eastern Biotech and Life Sciences, uBiome, Inc., DNA Genotek Inc. which is a subsidiary of OraSure Technologies, Inc., and XCode Life Sciences Private Limited.
In 2016, among these the 4 top players –Thermofisher Scientific, QIAGEN, Illumina Inc., and F. Hoffman-La Roche Ltd. accounted for around 65% of the overall market.
Major players are getting involved in investment in research and development activities so as to come up with a newer technologies and solutions.Request for Report Brochure - https://www.transparencymarketresearch.com/sample/sample.php?flag=S_id=12197According to a recent report by Transparency Market Research (TMR), the global genomics personalized health market is prognosticated to expand at a robust CAGR of 14.9% during the forecast period from 2017 to 2025.
In 2016, the market was valued around worth of US$7,243.0 mn, which is likely to reach around worth of US$25,112.5 mn, by 2025.genomics personalized health marketAs per the end users, the global genomics personalized health market is categorized into diagnostic centers, academics and research institutes, and so on.
On the basis of geography, the North America region’s genomics personalized health market held the maximum number of share all over the world, back in 2016.
Microbiome Sequencing Services Market Research Report: by Technology (Sequencing by Litigation (SBL), Sequencing by Synthesis (SBS), Others), Application (Gastrointestinal Diseases, Infectious Diseases, Others), and End User — Global Forecast till 2027Key PlayersSome of the key players in the global microbiome sequencing services market are Metabiomics Corp., Baseclear B.V., Clinical Microbiomics A/S, EPIBIOME, Merieux Nutrisciences Corporation, Microbiome Insights Inc., Microbiome Therapeutics, LLC., MR DNA, Rancho Biosciences, Second Genome, Ubiome, Inc., and Zymo Research Corp.Get Sample Report at https://www.marketresearchfuture.com/sample_request/7532Market HighlightsIt is estimated that the global Microbiome Sequencing Services Market Trends is expected to register a CAGR ~ 19.22% during the forecast period of 2018–2027, with an estimated market value of USD 555.1 million in 2017.Numerous factors such as high investment in next-generation sequencing, rising genome mapping programs in various countries, and the demand for microbiome research is anticipated to fuel the growth of the market.
Moreover, the increasing investments in next-generation sequencing by various public and private organizations have created a lucrative option for many companies to invest in providing microbiome sequencing services, leading to the overall growth of the market.
For instance, according to the data published by the Wall Street Journal in 2016, reported that venture funding in microbiome firms raised by 458.5% to USD 114.5 million from 2011 to 2015.However, the lack of skilled technicians, and ethical and legal issues related to genome sequencing, and unaffordability of microbiome sequencing services in certain economies is expected to curb the growth of microbiome sequencing services market.The global microbiome sequencing services market is currently dominated by many market players.
This product is a natural blend of prebiotics manufactured to help nurture and nourish beneficial microorganisms in the lower gut.
The market, based on technology, has been segmented into Sequencing by Litigation (SBL), Sequencing by Synthesis (SBS), short gun sequencing, targeted gene sequencing, RNA sequencing, and others.
The market, by application, has been further segmented into gastrointestinal diseases, infectious diseases, CNS diseases, oncology, and others.
The global genomics personalized health market is anticpated to be highly fragmented due to presence of large number of palyers in the regional and global market.
Some of the key players in the industry are Thermo Fisher Scientific, Inc., QIAGEN, Illumina, Inc., Bio-Rad Laboratories, Inc., Lonza Group, F. Hoffmann-La Roche AG, INVITAE Corporation, Interleukin Genetics Inc., Genetic Technologies Limited, Eastern Biotech and Life Sciences, uBiome, Inc., DNA Genotek Inc. which is a subsidiary of OraSure Technologies, Inc., and XCode Life Sciences Private Limited.
In 2016, among these the 4 top players –Thermofisher Scientific, QIAGEN, Illumina Inc., and F. Hoffman-La Roche Ltd. accounted for around 65% of the overall market.
Major players are getting involved in investment in research and development activities so as to come up with a newer technologies and solutions.Request for Report Brochure - https://www.transparencymarketresearch.com/sample/sample.php?flag=S_id=12197According to a recent report by Transparency Market Research (TMR), the global genomics personalized health market is prognosticated to expand at a robust CAGR of 14.9% during the forecast period from 2017 to 2025.
In 2016, the market was valued around worth of US$7,243.0 mn, which is likely to reach around worth of US$25,112.5 mn, by 2025.genomics personalized health marketAs per the end users, the global genomics personalized health market is categorized into diagnostic centers, academics and research institutes, and so on.
On the basis of geography, the North America region’s genomics personalized health market held the maximum number of share all over the world, back in 2016.
The global human microbiome therapeutics market size is expected to reach USD 1,544.6 million by 2027 according to a new study by Polaris Market Research.
The report “Human Microbiome Therapeutics Market Share, Size, Trends, Industry Analysis Report, By Product (Probiotics, Prebiotics, Medical Foods, and Prescription Drugs); By Therapeutic Area (Autoimmune Disorders, Dental Disorders, Digestive and Gastrointestinal Disorders, Dermatological Disorders, Infectious Disease, Metabolic Disorders, Oncology, and Others); By Indication (Acne Vulgaris, Atopic Dermatitis, Clostridium difficile Infection, Colorectal Cancer, Diabetes, Inflammatory Bowel Disease (IBD), Lactose Intolerance, Lung Cancer, Non-alcoholic steatohepatitis (NASH), Obesity, and Coeliac Disease); By Approach (Small Molecule Therapies, Single Strain Whole Bacteria, Microbial Consortia, Genetically Modified Single Strain Bacteria, Phage Cocktail, and Microbial Ecosystems), By Regions; Segment Forecast, 2020 –2027” gives a detailed insight into current market dynamics and provides analysis on future market growth.Microbiome refers to the residing micro-organisms genomes in the human body, particularly in the gut.
The human body comprises more than 100 trillion microbes and around 2 million microbe genomes.
These microbiota plays a significant role in the body’s physiological functions and includes viruses, bacteria, and fungi.
The majority of these are strict anaerobes, with fungi and archaebacteria comprising less than 1 per cent of the total population.Request for sample copy of this report @https://www.polarismarketresearch.com/industry-analysis/human-microbiome-therapeutics-market/request-for-sampleThe global market is driven by an increased focus on microbiome based early diagnosis of diseases, increase in the prevalence of diseases due to dysbiosis, rising collaborations, and strongly funded government backed microbiome research projects.
The aim is to create the largest human microbiome database from analyzing more than one million samples gathered from reproductive tract, gut, skin, and other organs in the next few years.Market participants such as Enterome Bioscience, Biotagenics, Seres Therapeutics, Oxidien Pharmaceuticals, LLC, BoobyBiome, 4D Pharma PLC, UBiome, Carbiotix, E.I.
Microbiome Sequencing Services Market Research Report: by Technology (Sequencing by Litigation (SBL), Sequencing by Synthesis (SBS), Others), Application (Gastrointestinal Diseases, Infectious Diseases, Others), and End User — Global Forecast till 2027Key PlayersSome of the key players in the global microbiome sequencing services market are Metabiomics Corp., Baseclear B.V., Clinical Microbiomics A/S, EPIBIOME, Merieux Nutrisciences Corporation, Microbiome Insights Inc., Microbiome Therapeutics, LLC., MR DNA, Rancho Biosciences, Second Genome, Ubiome, Inc., and Zymo Research Corp.Get Sample Report at https://www.marketresearchfuture.com/sample_request/7532Market HighlightsIt is estimated that the global Microbiome Sequencing Services Market Growth is expected to register a CAGR ~ 19.22% during the forecast period of 2018–2027, with an estimated market value of USD 555.1 million in 2017.Numerous factors such as high investment in next-generation sequencing, rising genome mapping programs in various countries, and the demand for microbiome research is anticipated to fuel the growth of the market.
Moreover, the increasing investments in next-generation sequencing by various public and private organizations have created a lucrative option for many companies to invest in providing microbiome sequencing services, leading to the overall growth of the market.
For instance, according to the data published by the Wall Street Journal in 2016, reported that venture funding in microbiome firms raised by 458.5% to USD 114.5 million from 2011 to 2015.However, the lack of skilled technicians, and ethical and legal issues related to genome sequencing, and unaffordability of microbiome sequencing services in certain economies is expected to curb the growth of microbiome sequencing services market.The global microbiome sequencing services market is currently dominated by many market players.
This product is a natural blend of prebiotics manufactured to help nurture and nourish beneficial microorganisms in the lower gut.
The market, based on technology, has been segmented into Sequencing by Litigation (SBL), Sequencing by Synthesis (SBS), short gun sequencing, targeted gene sequencing, RNA sequencing, and others.
The market, by application, has been further segmented into gastrointestinal diseases, infectious diseases, CNS diseases, oncology, and others.
The global human microbiome therapeutics market size is expected to reach USD 1,544.6 million by 2027 according to a new study by Polaris Market Research.
The report “Human Microbiome Therapeutics Market Share, Size, Trends, Industry Analysis Report, By Product (Probiotics, Prebiotics, Medical Foods, and Prescription Drugs); By Therapeutic Area (Autoimmune Disorders, Dental Disorders, Digestive and Gastrointestinal Disorders, Dermatological Disorders, Infectious Disease, Metabolic Disorders, Oncology, and Others); By Indication (Acne Vulgaris, Atopic Dermatitis, Clostridium difficile Infection, Colorectal Cancer, Diabetes, Inflammatory Bowel Disease (IBD), Lactose Intolerance, Lung Cancer, Non-alcoholic steatohepatitis (NASH), Obesity, and Coeliac Disease); By Approach (Small Molecule Therapies, Single Strain Whole Bacteria, Microbial Consortia, Genetically Modified Single Strain Bacteria, Phage Cocktail, and Microbial Ecosystems), By Regions; Segment Forecast, 2020 –2027” gives a detailed insight into current market dynamics and provides analysis on future market growth.Microbiome refers to the residing micro-organisms genomes in the human body, particularly in the gut.
The human body comprises more than 100 trillion microbes and around 2 million microbe genomes.
The majority of these are strict anaerobes, with fungi and archaebacteria comprising less than 1 per cent of the total population.Request for sample copy of this report @https://www.polarismarketresearch.com/industry-analysis/human-microbiome-therapeutics-market/request-for-sampleThe global market is driven by an increased focus on microbiome based early diagnosis of diseases, increase in the prevalence of diseases due to dysbiosis, rising collaborations, and strongly funded government backed microbiome research projects.
In November 2019, the Million Microbiome of Humans Project (MMHP) was launched in collaboration with France, Denmark, China, Latvia, Sweden and other countries to co-operate in meta-genomic research.
The aim is to create the largest human microbiome database from analyzing more than one million samples gathered from reproductive tract, gut, skin, and other organs in the next few years.Market participants such as Enterome Bioscience, Biotagenics, Seres Therapeutics, Oxidien Pharmaceuticals, LLC, BoobyBiome, 4D Pharma PLC, UBiome, Carbiotix, E.I.
The global human microbiome therapeutics market size is expected to reach USD 1,544.6 million by 2027 according to a new study by Polaris Market Research.
The report “Human Microbiome Therapeutics Market Share, Size, Trends, Industry Analysis Report, By Product (Probiotics, Prebiotics, Medical Foods, and Prescription Drugs); By Therapeutic Area (Autoimmune Disorders, Dental Disorders, Digestive and Gastrointestinal Disorders, Dermatological Disorders, Infectious Disease, Metabolic Disorders, Oncology, and Others); By Indication (Acne Vulgaris, Atopic Dermatitis, Clostridium difficile Infection, Colorectal Cancer, Diabetes, Inflammatory Bowel Disease (IBD), Lactose Intolerance, Lung Cancer, Non-alcoholic steatohepatitis (NASH), Obesity, and Coeliac Disease); By Approach (Small Molecule Therapies, Single Strain Whole Bacteria, Microbial Consortia, Genetically Modified Single Strain Bacteria, Phage Cocktail, and Microbial Ecosystems), By Regions; Segment Forecast, 2020 –2027” gives a detailed insight into current market dynamics and provides analysis on future market growth.Microbiome refers to the residing micro-organisms genomes in the human body, particularly in the gut.
The human body comprises more than 100 trillion microbes and around 2 million microbe genomes.
The majority of these are strict anaerobes, with fungi and archaebacteria comprising less than 1 per cent of the total population.Request for sample copy of this report @https://www.polarismarketresearch.com/industry-analysis/human-microbiome-therapeutics-market/request-for-sampleThe global market is driven by an increased focus on microbiome based early diagnosis of diseases, increase in the prevalence of diseases due to dysbiosis, rising collaborations, and strongly funded government backed microbiome research projects.
In November 2019, the Million Microbiome of Humans Project (MMHP) was launched in collaboration with France, Denmark, China, Latvia, Sweden and other countries to co-operate in meta-genomic research.
The aim is to create the largest human microbiome database from analyzing more than one million samples gathered from reproductive tract, gut, skin, and other organs in the next few years.Market participants such as Enterome Bioscience, Biotagenics, Seres Therapeutics, Oxidien Pharmaceuticals, LLC, BoobyBiome, 4D Pharma PLC, UBiome, Carbiotix, E.I.
Microbiome Sequencing Services Market Research Report: by Technology (Sequencing by Litigation (SBL), Sequencing by Synthesis (SBS), Others), Application (Gastrointestinal Diseases, Infectious Diseases, Others), and End User — Global Forecast till 2027Key PlayersSome of the key players in the global microbiome sequencing services market are Metabiomics Corp., Baseclear B.V., Clinical Microbiomics A/S, EPIBIOME, Merieux Nutrisciences Corporation, Microbiome Insights Inc., Microbiome Therapeutics, LLC., MR DNA, Rancho Biosciences, Second Genome, Ubiome, Inc., and Zymo Research Corp.Get Sample Report at https://www.marketresearchfuture.com/sample_request/7532Market HighlightsIt is estimated that the global Microbiome Sequencing Services Market is expected to register a CAGR ~ 19.22% during the forecast period of 2018–2027, with an estimated market value of USD 555.1 million in 2017.Numerous factors such as high investment in next-generation sequencing, rising genome mapping programs in various countries, and the demand for microbiome research is anticipated to fuel the growth of the market.
Moreover, the increasing investments in next-generation sequencing by various public and private organizations have created a lucrative option for many companies to invest in providing microbiome sequencing services, leading to the overall growth of the market.
For instance, according to the data published by the Wall Street Journal in 2016, reported that venture funding in microbiome firms raised by 458.5% to USD 114.5 million from 2011 to 2015.However, the lack of skilled technicians, and ethical and legal issues related to genome sequencing, and unaffordability of microbiome sequencing services in certain economies is expected to curb the growth of microbiome sequencing services market.The global microbiome sequencing services market is currently dominated by many market players.
This product is a natural blend of prebiotics manufactured to help nurture and nourish beneficial microorganisms in the lower gut.
The market, based on technology, has been segmented into Sequencing by Litigation (SBL), Sequencing by Synthesis (SBS), short gun sequencing, targeted gene sequencing, RNA sequencing, and others.
The market, by application, has been further segmented into gastrointestinal diseases, infectious diseases, CNS diseases, oncology, and others.
Microbiome Sequencing Services Market Research Report: by Technology (Sequencing by Litigation (SBL), Sequencing by Synthesis (SBS), Others), Application (Gastrointestinal Diseases, Infectious Diseases, Others), and End User — Global Forecast till 2027Key PlayersSome of the key players in the global microbiome sequencing services market are Metabiomics Corp., Baseclear B.V., Clinical Microbiomics A/S, EPIBIOME, Merieux Nutrisciences Corporation, Microbiome Insights Inc., Microbiome Therapeutics, LLC., MR DNA, Rancho Biosciences, Second Genome, Ubiome, Inc., and Zymo Research Corp.Get Sample Report at https://www.marketresearchfuture.com/sample_request/7532Market HighlightsIt is estimated that the global Microbiome Sequencing Services Market Trends is expected to register a CAGR ~ 19.22% during the forecast period of 2018–2027, with an estimated market value of USD 555.1 million in 2017.Numerous factors such as high investment in next-generation sequencing, rising genome mapping programs in various countries, and the demand for microbiome research is anticipated to fuel the growth of the market.
Moreover, the increasing investments in next-generation sequencing by various public and private organizations have created a lucrative option for many companies to invest in providing microbiome sequencing services, leading to the overall growth of the market.
For instance, according to the data published by the Wall Street Journal in 2016, reported that venture funding in microbiome firms raised by 458.5% to USD 114.5 million from 2011 to 2015.However, the lack of skilled technicians, and ethical and legal issues related to genome sequencing, and unaffordability of microbiome sequencing services in certain economies is expected to curb the growth of microbiome sequencing services market.The global microbiome sequencing services market is currently dominated by many market players.
This product is a natural blend of prebiotics manufactured to help nurture and nourish beneficial microorganisms in the lower gut.
The market, based on technology, has been segmented into Sequencing by Litigation (SBL), Sequencing by Synthesis (SBS), short gun sequencing, targeted gene sequencing, RNA sequencing, and others.
The market, by application, has been further segmented into gastrointestinal diseases, infectious diseases, CNS diseases, oncology, and others.
The global human microbiome therapeutics market size is expected to reach USD 1,544.6 million by 2027 according to a new study by Polaris Market Research.
The report “Human Microbiome Therapeutics Market Share, Size, Trends, Industry Analysis Report, By Product (Probiotics, Prebiotics, Medical Foods, and Prescription Drugs); By Therapeutic Area (Autoimmune Disorders, Dental Disorders, Digestive and Gastrointestinal Disorders, Dermatological Disorders, Infectious Disease, Metabolic Disorders, Oncology, and Others); By Indication (Acne Vulgaris, Atopic Dermatitis, Clostridium difficile Infection, Colorectal Cancer, Diabetes, Inflammatory Bowel Disease (IBD), Lactose Intolerance, Lung Cancer, Non-alcoholic steatohepatitis (NASH), Obesity, and Coeliac Disease); By Approach (Small Molecule Therapies, Single Strain Whole Bacteria, Microbial Consortia, Genetically Modified Single Strain Bacteria, Phage Cocktail, and Microbial Ecosystems), By Regions; Segment Forecast, 2020 –2027” gives a detailed insight into current market dynamics and provides analysis on future market growth.Microbiome refers to the residing micro-organisms genomes in the human body, particularly in the gut.
The human body comprises more than 100 trillion microbes and around 2 million microbe genomes.
The majority of these are strict anaerobes, with fungi and archaebacteria comprising less than 1 per cent of the total population.Get Sample copy of report: https://www.polarismarketresearch.com/industry-analysis/human-microbiome-therapeutics-market/request-for-sampleThe global market is driven by an increased focus on microbiome based early diagnosis of diseases, increase in the prevalence of diseases due to dysbiosis, rising collaborations, and strongly funded government backed microbiome research projects.
In November 2019, the Million Microbiome of Humans Project (MMHP) was launched in collaboration with France, Denmark, China, Latvia, Sweden and other countries to co-operate in meta-genomic research.
The aim is to create the largest human microbiome database from analyzing more than one million samples gathered from reproductive tract, gut, skin, and other organs in the next few years.Market participants such as Enterome Bioscience, Biotagenics, Seres Therapeutics, Oxidien Pharmaceuticals, LLC, BoobyBiome, 4D Pharma PLC, UBiome, Carbiotix, E.I.
Microbiome Sequencing Services Market Research Report: by Technology (Sequencing by Litigation (SBL), Sequencing by Synthesis (SBS), Others), Application (Gastrointestinal Diseases, Infectious Diseases, Others), and End User — Global Forecast till 2027Key PlayersSome of the key players in the global microbiome sequencing services market are Metabiomics Corp., Baseclear B.V., Clinical Microbiomics A/S, EPIBIOME, Merieux Nutrisciences Corporation, Microbiome Insights Inc., Microbiome Therapeutics, LLC., MR DNA, Rancho Biosciences, Second Genome, Ubiome, Inc., and Zymo Research Corp.Get Sample Report at https://www.marketresearchfuture.com/sample_request/7532Market HighlightsIt is estimated that the global Microbiome Sequencing Services Market Size is expected to register a CAGR ~ 19.22% during the forecast period of 2018–2027, with an estimated market value of USD 555.1 million in 2017.Numerous factors such as high investment in next-generation sequencing, rising genome mapping programs in various countries, and the demand for microbiome research is anticipated to fuel the growth of the market.
Moreover, the increasing investments in next-generation sequencing by various public and private organizations have created a lucrative option for many companies to invest in providing microbiome sequencing services, leading to the overall growth of the market.
For instance, according to the data published by the Wall Street Journal in 2016, reported that venture funding in microbiome firms raised by 458.5% to USD 114.5 million from 2011 to 2015.However, the lack of skilled technicians, and ethical and legal issues related to genome sequencing, and unaffordability of microbiome sequencing services in certain economies is expected to curb the growth of microbiome sequencing services market.The global microbiome sequencing services market is currently dominated by many market players.
This product is a natural blend of prebiotics manufactured to help nurture and nourish beneficial microorganisms in the lower gut.
The market, based on technology, has been segmented into Sequencing by Litigation (SBL), Sequencing by Synthesis (SBS), short gun sequencing, targeted gene sequencing, RNA sequencing, and others.
The market, by application, has been further segmented into gastrointestinal diseases, infectious diseases, CNS diseases, oncology, and others.
The latest trending report Global Microbiome Sequencing Services Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025 offered by DecisionDatabases.com is an informative study covering the market with detailed analysis.
The report will assist reader with better understanding and decision making.The global Microbiome Sequencing Services market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 16.5% in the forecast period of 2020 to 2025 and will expected to reach USD 1202.6 million by 2025, from USD 653.8 million in 2019.The Microbiome Sequencing Services market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.Final Report will cover the impact of COVID-19 on this industry.Browse the complete report and table of contents @ https://www.decisiondatabases.com/ip/38361-microbiome-sequencing-services-market-analysis-reportThe major players covered in Microbiome Sequencing Services are: Baseclear Openbiome Zymo Research Clinical-Microbiomics Microbiome Insights Molzym Metabiomics Microbiome Therapeutics Rancho Biosciences Resphera Biosciences Ubiome Merieux Nutrisciences Shanghai Realbio Technology DiversigenBy Type, Microbiome Sequencing Services market has been segmented into: Sequencing By Synthesis Sequencing By Ligation Sanger SequencingBy Application, Microbiome Sequencing Services has been segmented into: Pharmaceuticals Biotech Companies Academic AuthoritiesThe report offers in-depth assessment of the growth and other aspects of the Microbiome Sequencing Services market in important countries (regions), including: North America (United States, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia) South America (Brazil, Argentina, Colombia) Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)Download Free Sample Report of Global Microbiome Sequencing Services Market @ https://www.decisiondatabases.com/contact/download-sample-38361There are 14 Chapters to deeply display the Global Microbiome Sequencing Services market.1 Microbiome Sequencing Services Market Overview2 Company Profiles3 Market Competition, by Players4 Market Size by Regions5 North America Microbiome Sequencing Services Revenue by Countries6 Europe Microbiome Sequencing Services Revenue by Countries7 Asia-Pacific Microbiome Sequencing Services Revenue by Countries8 South America Microbiome Sequencing Services Revenue by Countries9 Middle East & Africa Revenue Microbiome Sequencing Services by Countries10 Market Size Segment by Type11 Global Microbiome Sequencing Services Market Segment by Application12 Global Microbiome Sequencing Services Market Size Forecast (2021-2025)13 Research Findings and Conclusion14 AppendixPurchase the complete Global Microbiome Sequencing Services Market Research Report @ https://www.decisiondatabases.com/contact/buy-now-38361Other Reports by DecisionDatabases.com:Global Microbiome Therapeutics Market 2019 by Company, Regions, Type and Application, Forecast to 2024Global Human Microbiome Market by Manufacturers, Countries, Type and Application, Forecast to 2023About-Us:DecisionDatabases.com is a global business research reports provider, enriching decision makers and strategists with qualitative statistics.
DecisionDatabases.com is proficient in providing syndicated research report, customized research reports, company profiles and industry databases across multiple domains.Our expert research analysts have been trained to map client’s research requirements to the correct research resource leading to a distinctive edge over its competitors.
We provide intellectual, precise and meaningful data at a lightning speed.For more details:DecisionDatabases.comE-Mail: [email protected]: +91 9028057900Web: https://www.decisiondatabases.com/
Microbiome Sequencing Services Market Research Report: by Technology (Sequencing by Litigation (SBL), Sequencing by Synthesis (SBS), Others), Application (Gastrointestinal Diseases, Infectious Diseases, Others), and End User — Global Forecast till 2027Key PlayersSome of the key players in the global microbiome sequencing services market are Metabiomics Corp., Baseclear B.V., Clinical Microbiomics A/S, EPIBIOME, Merieux Nutrisciences Corporation, Microbiome Insights Inc., Microbiome Therapeutics, LLC., MR DNA, Rancho Biosciences, Second Genome, Ubiome, Inc., and Zymo Research Corp.Get Sample Report at https://www.marketresearchfuture.com/sample_request/7532Market HighlightsIt is estimated that the global Microbiome Sequencing Services Market Trends is expected to register a CAGR ~ 19.22% during the forecast period of 2018–2027, with an estimated market value of USD 555.1 million in 2017.Numerous factors such as high investment in next-generation sequencing, rising genome mapping programs in various countries, and the demand for microbiome research is anticipated to fuel the growth of the market.
Moreover, the increasing investments in next-generation sequencing by various public and private organizations have created a lucrative option for many companies to invest in providing microbiome sequencing services, leading to the overall growth of the market.
For instance, according to the data published by the Wall Street Journal in 2016, reported that venture funding in microbiome firms raised by 458.5% to USD 114.5 million from 2011 to 2015.However, the lack of skilled technicians, and ethical and legal issues related to genome sequencing, and unaffordability of microbiome sequencing services in certain economies is expected to curb the growth of microbiome sequencing services market.The global microbiome sequencing services market is currently dominated by many market players.
This product is a natural blend of prebiotics manufactured to help nurture and nourish beneficial microorganisms in the lower gut.
The market, based on technology, has been segmented into Sequencing by Litigation (SBL), Sequencing by Synthesis (SBS), short gun sequencing, targeted gene sequencing, RNA sequencing, and others.
The market, by application, has been further segmented into gastrointestinal diseases, infectious diseases, CNS diseases, oncology, and others.
The global human microbiome therapeutics market size is expected to reach USD 1,544.6 million by 2027 according to a new study by Polaris Market Research.
The report “Human Microbiome Therapeutics Market Share, Size, Trends, Industry Analysis Report, By Product (Probiotics, Prebiotics, Medical Foods, and Prescription Drugs); By Therapeutic Area (Autoimmune Disorders, Dental Disorders, Digestive and Gastrointestinal Disorders, Dermatological Disorders, Infectious Disease, Metabolic Disorders, Oncology, and Others); By Indication (Acne Vulgaris, Atopic Dermatitis, Clostridium difficile Infection, Colorectal Cancer, Diabetes, Inflammatory Bowel Disease (IBD), Lactose Intolerance, Lung Cancer, Non-alcoholic steatohepatitis (NASH), Obesity, and Coeliac Disease); By Approach (Small Molecule Therapies, Single Strain Whole Bacteria, Microbial Consortia, Genetically Modified Single Strain Bacteria, Phage Cocktail, and Microbial Ecosystems), By Regions; Segment Forecast, 2020 –2027” gives a detailed insight into current market dynamics and provides analysis on future market growth.Microbiome refers to the residing micro-organisms genomes in the human body, particularly in the gut.
The human body comprises more than 100 trillion microbes and around 2 million microbe genomes.
These microbiota plays a significant role in the body’s physiological functions and includes viruses, bacteria, and fungi.
The majority of these are strict anaerobes, with fungi and archaebacteria comprising less than 1 per cent of the total population.Request for sample copy of this report @https://www.polarismarketresearch.com/industry-analysis/human-microbiome-therapeutics-market/request-for-sampleThe global market is driven by an increased focus on microbiome based early diagnosis of diseases, increase in the prevalence of diseases due to dysbiosis, rising collaborations, and strongly funded government backed microbiome research projects.
The aim is to create the largest human microbiome database from analyzing more than one million samples gathered from reproductive tract, gut, skin, and other organs in the next few years.Market participants such as Enterome Bioscience, Biotagenics, Seres Therapeutics, Oxidien Pharmaceuticals, LLC, BoobyBiome, 4D Pharma PLC, UBiome, Carbiotix, E.I.
The global human microbiome therapeutics market size is expected to reach USD 1,544.6 million by 2027 according to a new study by Polaris Market Research.
The report “Human Microbiome Therapeutics Market Share, Size, Trends, Industry Analysis Report, By Product (Probiotics, Prebiotics, Medical Foods, and Prescription Drugs); By Therapeutic Area (Autoimmune Disorders, Dental Disorders, Digestive and Gastrointestinal Disorders, Dermatological Disorders, Infectious Disease, Metabolic Disorders, Oncology, and Others); By Indication (Acne Vulgaris, Atopic Dermatitis, Clostridium difficile Infection, Colorectal Cancer, Diabetes, Inflammatory Bowel Disease (IBD), Lactose Intolerance, Lung Cancer, Non-alcoholic steatohepatitis (NASH), Obesity, and Coeliac Disease); By Approach (Small Molecule Therapies, Single Strain Whole Bacteria, Microbial Consortia, Genetically Modified Single Strain Bacteria, Phage Cocktail, and Microbial Ecosystems), By Regions; Segment Forecast, 2020 –2027” gives a detailed insight into current market dynamics and provides analysis on future market growth.Microbiome refers to the residing micro-organisms genomes in the human body, particularly in the gut.
The human body comprises more than 100 trillion microbes and around 2 million microbe genomes.
The majority of these are strict anaerobes, with fungi and archaebacteria comprising less than 1 per cent of the total population.Request for sample copy of this report @https://www.polarismarketresearch.com/industry-analysis/human-microbiome-therapeutics-market/request-for-sampleThe global market is driven by an increased focus on microbiome based early diagnosis of diseases, increase in the prevalence of diseases due to dysbiosis, rising collaborations, and strongly funded government backed microbiome research projects.
In November 2019, the Million Microbiome of Humans Project (MMHP) was launched in collaboration with France, Denmark, China, Latvia, Sweden and other countries to co-operate in meta-genomic research.
The aim is to create the largest human microbiome database from analyzing more than one million samples gathered from reproductive tract, gut, skin, and other organs in the next few years.Market participants such as Enterome Bioscience, Biotagenics, Seres Therapeutics, Oxidien Pharmaceuticals, LLC, BoobyBiome, 4D Pharma PLC, UBiome, Carbiotix, E.I.
Microbiome Sequencing Services Market Research Report: by Technology (Sequencing by Litigation (SBL), Sequencing by Synthesis (SBS), Others), Application (Gastrointestinal Diseases, Infectious Diseases, Others), and End User — Global Forecast till 2027Key PlayersSome of the key players in the global microbiome sequencing services market are Metabiomics Corp., Baseclear B.V., Clinical Microbiomics A/S, EPIBIOME, Merieux Nutrisciences Corporation, Microbiome Insights Inc., Microbiome Therapeutics, LLC., MR DNA, Rancho Biosciences, Second Genome, Ubiome, Inc., and Zymo Research Corp.Get Sample Report at https://www.marketresearchfuture.com/sample_request/7532Market HighlightsIt is estimated that the global Microbiome Sequencing Services Market is expected to register a CAGR ~ 19.22% during the forecast period of 2018–2027, with an estimated market value of USD 555.1 million in 2017.Numerous factors such as high investment in next-generation sequencing, rising genome mapping programs in various countries, and the demand for microbiome research is anticipated to fuel the growth of the market.
Moreover, the increasing investments in next-generation sequencing by various public and private organizations have created a lucrative option for many companies to invest in providing microbiome sequencing services, leading to the overall growth of the market.
For instance, according to the data published by the Wall Street Journal in 2016, reported that venture funding in microbiome firms raised by 458.5% to USD 114.5 million from 2011 to 2015.However, the lack of skilled technicians, and ethical and legal issues related to genome sequencing, and unaffordability of microbiome sequencing services in certain economies is expected to curb the growth of microbiome sequencing services market.The global microbiome sequencing services market is currently dominated by many market players.
This product is a natural blend of prebiotics manufactured to help nurture and nourish beneficial microorganisms in the lower gut.
The market, based on technology, has been segmented into Sequencing by Litigation (SBL), Sequencing by Synthesis (SBS), short gun sequencing, targeted gene sequencing, RNA sequencing, and others.
The market, by application, has been further segmented into gastrointestinal diseases, infectious diseases, CNS diseases, oncology, and others.
The global human microbiome therapeutics market size is expected to reach USD 1,544.6 million by 2027 according to a new study by Polaris Market Research.
The report “Human Microbiome Therapeutics Market Share, Size, Trends, Industry Analysis Report, By Product (Probiotics, Prebiotics, Medical Foods, and Prescription Drugs); By Therapeutic Area (Autoimmune Disorders, Dental Disorders, Digestive and Gastrointestinal Disorders, Dermatological Disorders, Infectious Disease, Metabolic Disorders, Oncology, and Others); By Indication (Acne Vulgaris, Atopic Dermatitis, Clostridium difficile Infection, Colorectal Cancer, Diabetes, Inflammatory Bowel Disease (IBD), Lactose Intolerance, Lung Cancer, Non-alcoholic steatohepatitis (NASH), Obesity, and Coeliac Disease); By Approach (Small Molecule Therapies, Single Strain Whole Bacteria, Microbial Consortia, Genetically Modified Single Strain Bacteria, Phage Cocktail, and Microbial Ecosystems), By Regions; Segment Forecast, 2020 –2027” gives a detailed insight into current market dynamics and provides analysis on future market growth.Microbiome refers to the residing micro-organisms genomes in the human body, particularly in the gut.
The human body comprises more than 100 trillion microbes and around 2 million microbe genomes.
The majority of these are strict anaerobes, with fungi and archaebacteria comprising less than 1 per cent of the total population.Get Sample copy of report: https://www.polarismarketresearch.com/industry-analysis/human-microbiome-therapeutics-market/request-for-sampleThe global market is driven by an increased focus on microbiome based early diagnosis of diseases, increase in the prevalence of diseases due to dysbiosis, rising collaborations, and strongly funded government backed microbiome research projects.
In November 2019, the Million Microbiome of Humans Project (MMHP) was launched in collaboration with France, Denmark, China, Latvia, Sweden and other countries to co-operate in meta-genomic research.
The aim is to create the largest human microbiome database from analyzing more than one million samples gathered from reproductive tract, gut, skin, and other organs in the next few years.Market participants such as Enterome Bioscience, Biotagenics, Seres Therapeutics, Oxidien Pharmaceuticals, LLC, BoobyBiome, 4D Pharma PLC, UBiome, Carbiotix, E.I.
The latest trending report Global Microbiome Sequencing Services Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025 offered by DecisionDatabases.com is an informative study covering the market with detailed analysis.
The report will assist reader with better understanding and decision making.The global Microbiome Sequencing Services market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 16.5% in the forecast period of 2020 to 2025 and will expected to reach USD 1202.6 million by 2025, from USD 653.8 million in 2019.The Microbiome Sequencing Services market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.Final Report will cover the impact of COVID-19 on this industry.Browse the complete report and table of contents @ https://www.decisiondatabases.com/ip/38361-microbiome-sequencing-services-market-analysis-reportThe major players covered in Microbiome Sequencing Services are: Baseclear Openbiome Zymo Research Clinical-Microbiomics Microbiome Insights Molzym Metabiomics Microbiome Therapeutics Rancho Biosciences Resphera Biosciences Ubiome Merieux Nutrisciences Shanghai Realbio Technology DiversigenBy Type, Microbiome Sequencing Services market has been segmented into: Sequencing By Synthesis Sequencing By Ligation Sanger SequencingBy Application, Microbiome Sequencing Services has been segmented into: Pharmaceuticals Biotech Companies Academic AuthoritiesThe report offers in-depth assessment of the growth and other aspects of the Microbiome Sequencing Services market in important countries (regions), including: North America (United States, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia) South America (Brazil, Argentina, Colombia) Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)Download Free Sample Report of Global Microbiome Sequencing Services Market @ https://www.decisiondatabases.com/contact/download-sample-38361There are 14 Chapters to deeply display the Global Microbiome Sequencing Services market.1 Microbiome Sequencing Services Market Overview2 Company Profiles3 Market Competition, by Players4 Market Size by Regions5 North America Microbiome Sequencing Services Revenue by Countries6 Europe Microbiome Sequencing Services Revenue by Countries7 Asia-Pacific Microbiome Sequencing Services Revenue by Countries8 South America Microbiome Sequencing Services Revenue by Countries9 Middle East & Africa Revenue Microbiome Sequencing Services by Countries10 Market Size Segment by Type11 Global Microbiome Sequencing Services Market Segment by Application12 Global Microbiome Sequencing Services Market Size Forecast (2021-2025)13 Research Findings and Conclusion14 AppendixPurchase the complete Global Microbiome Sequencing Services Market Research Report @ https://www.decisiondatabases.com/contact/buy-now-38361Other Reports by DecisionDatabases.com:Global Microbiome Therapeutics Market 2019 by Company, Regions, Type and Application, Forecast to 2024Global Human Microbiome Market by Manufacturers, Countries, Type and Application, Forecast to 2023About-Us:DecisionDatabases.com is a global business research reports provider, enriching decision makers and strategists with qualitative statistics.
DecisionDatabases.com is proficient in providing syndicated research report, customized research reports, company profiles and industry databases across multiple domains.Our expert research analysts have been trained to map client’s research requirements to the correct research resource leading to a distinctive edge over its competitors.
We provide intellectual, precise and meaningful data at a lightning speed.For more details:DecisionDatabases.comE-Mail: [email protected]: +91 9028057900Web: https://www.decisiondatabases.com/
The global genomics personalized health market is anticpated to be highly fragmented due to presence of large number of palyers in the regional and global market.
Some of the key players in the industry are Thermo Fisher Scientific, Inc., QIAGEN, Illumina, Inc., Bio-Rad Laboratories, Inc., Lonza Group, F. Hoffmann-La Roche AG, INVITAE Corporation, Interleukin Genetics Inc., Genetic Technologies Limited, Eastern Biotech and Life Sciences, uBiome, Inc., DNA Genotek Inc. which is a subsidiary of OraSure Technologies, Inc., and XCode Life Sciences Private Limited.
In 2016, among these the 4 top players –Thermofisher Scientific, QIAGEN, Illumina Inc., and F. Hoffman-La Roche Ltd. accounted for around 65% of the overall market.
Major players are getting involved in investment in research and development activities so as to come up with a newer technologies and solutions.Request for Report Brochure - https://www.transparencymarketresearch.com/sample/sample.php?flag=S_id=12197According to a recent report by Transparency Market Research (TMR), the global genomics personalized health market is prognosticated to expand at a robust CAGR of 14.9% during the forecast period from 2017 to 2025.
In 2016, the market was valued around worth of US$7,243.0 mn, which is likely to reach around worth of US$25,112.5 mn, by 2025.genomics personalized health marketAs per the end users, the global genomics personalized health market is categorized into diagnostic centers, academics and research institutes, and so on.
On the basis of geography, the North America region’s genomics personalized health market held the maximum number of share all over the world, back in 2016.
The global genomics personalized health market is anticpated to be highly fragmented due to presence of large number of palyers in the regional and global market.
Some of the key players in the industry are Thermo Fisher Scientific, Inc., QIAGEN, Illumina, Inc., Bio-Rad Laboratories, Inc., Lonza Group, F. Hoffmann-La Roche AG, INVITAE Corporation, Interleukin Genetics Inc., Genetic Technologies Limited, Eastern Biotech and Life Sciences, uBiome, Inc., DNA Genotek Inc. which is a subsidiary of OraSure Technologies, Inc., and XCode Life Sciences Private Limited.
In 2016, among these the 4 top players –Thermofisher Scientific, QIAGEN, Illumina Inc., and F. Hoffman-La Roche Ltd. accounted for around 65% of the overall market.
Major players are getting involved in investment in research and development activities so as to come up with a newer technologies and solutions.Request for Report Brochure - https://www.transparencymarketresearch.com/sample/sample.php?flag=S_id=12197According to a recent report by Transparency Market Research (TMR), the global genomics personalized health market is prognosticated to expand at a robust CAGR of 14.9% during the forecast period from 2017 to 2025.
In 2016, the market was valued around worth of US$7,243.0 mn, which is likely to reach around worth of US$25,112.5 mn, by 2025.genomics personalized health marketAs per the end users, the global genomics personalized health market is categorized into diagnostic centers, academics and research institutes, and so on.
On the basis of geography, the North America region’s genomics personalized health market held the maximum number of share all over the world, back in 2016.
Microbiome Sequencing Services Market Research Report: by Technology (Sequencing by Litigation (SBL), Sequencing by Synthesis (SBS), Others), Application (Gastrointestinal Diseases, Infectious Diseases, Others), and End User — Global Forecast till 2027Key PlayersSome of the key players in the global microbiome sequencing services market are Metabiomics Corp., Baseclear B.V., Clinical Microbiomics A/S, EPIBIOME, Merieux Nutrisciences Corporation, Microbiome Insights Inc., Microbiome Therapeutics, LLC., MR DNA, Rancho Biosciences, Second Genome, Ubiome, Inc., and Zymo Research Corp.Get Sample Report at https://www.marketresearchfuture.com/sample_request/7532Market HighlightsIt is estimated that the global Microbiome Sequencing Services Market Growth is expected to register a CAGR ~ 19.22% during the forecast period of 2018–2027, with an estimated market value of USD 555.1 million in 2017.Numerous factors such as high investment in next-generation sequencing, rising genome mapping programs in various countries, and the demand for microbiome research is anticipated to fuel the growth of the market.
Moreover, the increasing investments in next-generation sequencing by various public and private organizations have created a lucrative option for many companies to invest in providing microbiome sequencing services, leading to the overall growth of the market.
For instance, according to the data published by the Wall Street Journal in 2016, reported that venture funding in microbiome firms raised by 458.5% to USD 114.5 million from 2011 to 2015.However, the lack of skilled technicians, and ethical and legal issues related to genome sequencing, and unaffordability of microbiome sequencing services in certain economies is expected to curb the growth of microbiome sequencing services market.The global microbiome sequencing services market is currently dominated by many market players.
This product is a natural blend of prebiotics manufactured to help nurture and nourish beneficial microorganisms in the lower gut.
The market, based on technology, has been segmented into Sequencing by Litigation (SBL), Sequencing by Synthesis (SBS), short gun sequencing, targeted gene sequencing, RNA sequencing, and others.
The market, by application, has been further segmented into gastrointestinal diseases, infectious diseases, CNS diseases, oncology, and others.
The global human microbiome therapeutics market size is expected to reach USD 1,544.6 million by 2027 according to a new study by Polaris Market Research.
The report “Human Microbiome Therapeutics Market Share, Size, Trends, Industry Analysis Report, By Product (Probiotics, Prebiotics, Medical Foods, and Prescription Drugs); By Therapeutic Area (Autoimmune Disorders, Dental Disorders, Digestive and Gastrointestinal Disorders, Dermatological Disorders, Infectious Disease, Metabolic Disorders, Oncology, and Others); By Indication (Acne Vulgaris, Atopic Dermatitis, Clostridium difficile Infection, Colorectal Cancer, Diabetes, Inflammatory Bowel Disease (IBD), Lactose Intolerance, Lung Cancer, Non-alcoholic steatohepatitis (NASH), Obesity, and Coeliac Disease); By Approach (Small Molecule Therapies, Single Strain Whole Bacteria, Microbial Consortia, Genetically Modified Single Strain Bacteria, Phage Cocktail, and Microbial Ecosystems), By Regions; Segment Forecast, 2020 –2027” gives a detailed insight into current market dynamics and provides analysis on future market growth.Microbiome refers to the residing micro-organisms genomes in the human body, particularly in the gut.
The human body comprises more than 100 trillion microbes and around 2 million microbe genomes.
The majority of these are strict anaerobes, with fungi and archaebacteria comprising less than 1 per cent of the total population.Request for sample copy of this report @https://www.polarismarketresearch.com/industry-analysis/human-microbiome-therapeutics-market/request-for-sampleThe global market is driven by an increased focus on microbiome based early diagnosis of diseases, increase in the prevalence of diseases due to dysbiosis, rising collaborations, and strongly funded government backed microbiome research projects.
In November 2019, the Million Microbiome of Humans Project (MMHP) was launched in collaboration with France, Denmark, China, Latvia, Sweden and other countries to co-operate in meta-genomic research.
The aim is to create the largest human microbiome database from analyzing more than one million samples gathered from reproductive tract, gut, skin, and other organs in the next few years.Market participants such as Enterome Bioscience, Biotagenics, Seres Therapeutics, Oxidien Pharmaceuticals, LLC, BoobyBiome, 4D Pharma PLC, UBiome, Carbiotix, E.I.
Microbiome Sequencing Services Market Research Report: by Technology (Sequencing by Litigation (SBL), Sequencing by Synthesis (SBS), Others), Application (Gastrointestinal Diseases, Infectious Diseases, Others), and End User — Global Forecast till 2027Key PlayersSome of the key players in the global microbiome sequencing services market are Metabiomics Corp., Baseclear B.V., Clinical Microbiomics A/S, EPIBIOME, Merieux Nutrisciences Corporation, Microbiome Insights Inc., Microbiome Therapeutics, LLC., MR DNA, Rancho Biosciences, Second Genome, Ubiome, Inc., and Zymo Research Corp.Get Sample Report at https://www.marketresearchfuture.com/sample_request/7532Market HighlightsIt is estimated that the global Microbiome Sequencing Services Market Trends is expected to register a CAGR ~ 19.22% during the forecast period of 2018–2027, with an estimated market value of USD 555.1 million in 2017.Numerous factors such as high investment in next-generation sequencing, rising genome mapping programs in various countries, and the demand for microbiome research is anticipated to fuel the growth of the market.
Moreover, the increasing investments in next-generation sequencing by various public and private organizations have created a lucrative option for many companies to invest in providing microbiome sequencing services, leading to the overall growth of the market.
For instance, according to the data published by the Wall Street Journal in 2016, reported that venture funding in microbiome firms raised by 458.5% to USD 114.5 million from 2011 to 2015.However, the lack of skilled technicians, and ethical and legal issues related to genome sequencing, and unaffordability of microbiome sequencing services in certain economies is expected to curb the growth of microbiome sequencing services market.The global microbiome sequencing services market is currently dominated by many market players.
This product is a natural blend of prebiotics manufactured to help nurture and nourish beneficial microorganisms in the lower gut.
The market, based on technology, has been segmented into Sequencing by Litigation (SBL), Sequencing by Synthesis (SBS), short gun sequencing, targeted gene sequencing, RNA sequencing, and others.
The market, by application, has been further segmented into gastrointestinal diseases, infectious diseases, CNS diseases, oncology, and others.
Microbiome Sequencing Services Market Research Report: by Technology (Sequencing by Litigation (SBL), Sequencing by Synthesis (SBS), Others), Application (Gastrointestinal Diseases, Infectious Diseases, Others), and End User — Global Forecast till 2027Key PlayersSome of the key players in the global microbiome sequencing services market are Metabiomics Corp., Baseclear B.V., Clinical Microbiomics A/S, EPIBIOME, Merieux Nutrisciences Corporation, Microbiome Insights Inc., Microbiome Therapeutics, LLC., MR DNA, Rancho Biosciences, Second Genome, Ubiome, Inc., and Zymo Research Corp.Get Sample Report at https://www.marketresearchfuture.com/sample_request/7532Market HighlightsIt is estimated that the global Microbiome Sequencing Services Market Size is expected to register a CAGR ~ 19.22% during the forecast period of 2018–2027, with an estimated market value of USD 555.1 million in 2017.Numerous factors such as high investment in next-generation sequencing, rising genome mapping programs in various countries, and the demand for microbiome research is anticipated to fuel the growth of the market.
Moreover, the increasing investments in next-generation sequencing by various public and private organizations have created a lucrative option for many companies to invest in providing microbiome sequencing services, leading to the overall growth of the market.
For instance, according to the data published by the Wall Street Journal in 2016, reported that venture funding in microbiome firms raised by 458.5% to USD 114.5 million from 2011 to 2015.However, the lack of skilled technicians, and ethical and legal issues related to genome sequencing, and unaffordability of microbiome sequencing services in certain economies is expected to curb the growth of microbiome sequencing services market.The global microbiome sequencing services market is currently dominated by many market players.
This product is a natural blend of prebiotics manufactured to help nurture and nourish beneficial microorganisms in the lower gut.
The market, based on technology, has been segmented into Sequencing by Litigation (SBL), Sequencing by Synthesis (SBS), short gun sequencing, targeted gene sequencing, RNA sequencing, and others.
The market, by application, has been further segmented into gastrointestinal diseases, infectious diseases, CNS diseases, oncology, and others.